Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
Authors
Keywords
miRNA-21, Gastric cancer, P-glycoprotein
Journal
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 72, Issue 1, Pages 275-282
Publisher
Springer Nature
Online
2015-02-09
DOI
10.1007/s12013-014-0450-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
- (2014) Yasutsuna Sasaki et al. CANCER SCIENCE
- Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel
- (2013) Hao Wu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
- (2013) Longlong Bao et al. CANCER LETTERS
- Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
- (2013) X. Wang et al. Clinical & Translational Oncology
- miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer
- (2013) Dingzhi Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- High level of serum AMBP is associated with poor response to paclitaxel–capecitabine chemotherapy in advanced gastric cancer patients
- (2013) Hao Huang et al. MEDICAL ONCOLOGY
- miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells
- (2013) Xue Liu et al. PLoS One
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
- (2012) A. Gutiérrez-González et al. APOPTOSIS
- Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
- (2012) Koichiro Haruki et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
- (2012) Takayuki Ando et al. Gastric Cancer
- microRNAs in cancer management
- (2012) Yi W Kong et al. LANCET ONCOLOGY
- Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine
- (2012) Jingwei Yu et al. MEDICAL ONCOLOGY
- Src family kinases and paclitaxel sensitivity
- (2011) Xiao-Feng Le et al. CANCER BIOLOGY & THERAPY
- A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells
- (2011) Hong Qiu et al. CANCER LETTERS
- Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
- (2011) Shuling Huang et al. CANCER LETTERS
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
- (2010) Yu Ren et al. BMC CANCER
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
- (2010) Y.-j. Mi et al. CANCER RESEARCH
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Multidrug Resistance Through the Spectacle of P-Glycoprotein
- (2009) Katalin Goda et al. CURRENT CANCER DRUG TARGETS
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Biological principles of microRNA-mediated regulation: shared themes amid diversity
- (2008) Alex S. Flynt et al. NATURE REVIEWS GENETICS
- Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2
- (2007) Denis Selimovic et al. CELLULAR SIGNALLING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started